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Abstract
Repair of the lung epithelium after injury is a critical component for
resolution; however, the processes necessary to drive epithelial
resolution are not clearly defined. Published data demonstrate that
Foxp31 regulatory T cells (Tregs) enhance alveolar epithelial
proliferation after injury, and Tregs in vitro directly promote type II
alveolar epithelial cell (AT2) proliferation, in part by a contact-
independent mechanism. Therefore, we sought to determine the
contribution of Treg-specific expression of a growth factor that is
known to be important in lung repair, keratinocyte growth factor
(kgf). The data demonstrate that Tregs express kgf and that
Treg-specific expression of kgf regulates alveolar epithelial
proliferation during the resolution phase of acute lung injury and in a
model of regenerative alveologenesis in vivo. In vitro experiments
demonstrate that AT2 cells cocultured with Tregs lacking kgf have
decreased rates of proliferation compared with AT2 cells cocultured
with wild-type Tregs. Moreover, Tregs isolated from lung tissue
and grown in culture express higher levels of two growth factors that
are important for lung repair (kgf and amphiregulin) compared
with Tregs isolated from splenic tissue. Lastly, Tregs isolated from
human lung tissue can be stimulated ex vivo to induce kgf expression.
This study reveals mechanisms by which Tregs direct tissue-
reparative effects during resolution after acute lung injury,
further supporting the emerging role of Tregs in tissue repair.
Keywords: regulatory T cells; Foxp3; acute lung injury;
keratinocyte growth factor; alveolar epithelial repair
Clinical Relevance
Epithelial repair is an essential component for optimal
resolution from acute lung injury. Foxp31 regulatory T cells
enhance alveolar epithelial proliferation through their
expression of keratinocyte growth factor. This study supports
an expanding role for Foxp31 Treg cells in lung tissue repair.
In acute or chronic injury, the lung epithelium
is often injured and its normal functions
are impeded. Failure to regenerate the lung
epithelium contributes to poor resolution
and inadequate reparative processes in lung
diseases such as acute respiratory distress
syndrome (ARDS) and pneumonia, and
leads to pulmonary scarring and fibrosis (1).
Resolution from injury is not simply relief
from injurious stimuli, but rather an actively
regulated program involving removal of
apoptotic neutrophils, remodeling of matrix,
repair of alveolar epithelium, and
reabsorption of alveolar edema (2–5).
The epithelial cells involved in repair
include local progenitor cells that migrate to
the site of injury, where they proliferate and
differentiate to repair the epithelial layer.
Lung epithelial cells renew slowly in the
absence of injury, but are stimulated to
self-renew during injury (6, 7). In the
alveolar space, type II alveolar epithelial
(AT2) cells proliferate both at steady state
and in response to injury, whereas type I
alveolar epithelial (AT1) cells are generally
regarded as nonproliferating (8, 9). Pulse-
labeling and lineage-tracing experiments
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have shown that AT2 cells give rise to AT1
cells during development and in response
to injury (8–10).
It has been proposed that the immune
system plays an important role in enhancing
barrier function and promoting resolution
(1, 11, 12). Tregs are a distinct population
of CD41 lymphocytes that are identified
by their expression of the transcription
factor Forkhead homeobox protein-3
(Foxp3), and suppress or downregulate
immune responses (13, 14). Others have
shown a central role for Tregs in the
resolution of experimental acute lung
injury (ALI) (15, 16).
More recently, several groups have shown
that Tregs play a role in tissue repair through
expression of the growth factor amphiregulin
(Areg) (17, 18). In a previous study, we
demonstrated that Tregs enhance alveolar
epithelial proliferation after injury in vivo and
directly promote AT2 proliferation in vitro, in
part by a contact-independent mechanism,
suggesting that a soluble factor may be
important in this process (15). However, the
mechanisms by which Tregs facilitate
resolution are far from clear.
In the study presented here, we sought
to determine whether Treg expression of
a growth factor, keratinocyte growth factor
(kgf), is a potential mechanism by which
Tregs promote lung repair. kgf (also called
fibroblast growth factor 7 [Fgf-7]) can be
expressed by several cell types (19, 20). One
lymphocyte subset, gd1 T cells, has also
been shown to express kgf in the skin and
intestine (21, 22). kgf plays an important
role in lung repair and mediates protective
effects on epithelial cells, as previously
described (19, 23–25). Interestingly,
human subjects administered recombinant
human KGF and then exposed to inhaled
lipopolysaccharide (LPS) were found to
have an increased phagocytic uptake of
bacteria by alveolar macrophages and
increased bronchoalveolar lavage (BAL)
concentrations of surfactant protein D, matrix
metallopeptidase 9 (MMP-9), granulocyte-
macrophage colony-stimulating factor (GM-
CSF), and IL-1Ra (23). These studies led to a
clinical trial for recombinant KGF in ARDS
(26). Given the increase of Foxp31 Tregs in
the lung after injury and our previous report of
a contact-independent effect on AT2
proliferation, we hypothesized that one
mechanism by which Tregs promote epithelial
repair is through direct expression of kgf.
The data herein demonstrate that Tregs
express kgf, and Treg-specific expression of
kgf plays a role in enhancing alveolar
epithelial proliferation both in vivo and
in vitro. Additionally, Tregs isolated from
human lungs also expressed KGF and
AREG after stimulation. This study
enhances our mechanistic understanding
of Treg-directed effects on the reparative
process during lung resolution and
document an emerging role for Foxp31
Tregs in tissue repair.
Materials and Methods
Mice
C57BL/6J and 129S1/SvlmJ mice (8–12 wk
of age) were obtained from The Jackson
Laboratory (Bar Harbor, ME) and colonies
were maintained at the University of North
Carolina. SP-CGFP mice were a gift from
Dr. John K. Heath (University of
Birmingham) (27). Foxp3DTR and
Foxp3EGFP mice were generated by
Dr. Alexander Y. Rudensky and Dr. Talal
Chatila, respectively (obtained from The
Jackson Laboratory) (28, 29). Foxp3EGFP
mice express green fluorescent protein
(GFP) downstream of the endogenous
Foxp3 stop codon, resulting in fluorescence
of all Tregs (28). The Foxp3DTR mice
express the human diphtheria toxin receptor
(DTR) along with GFP, and genes for both
DTR and GPF have been inserted into the
39 untranslated region of the Foxp3 locus
(29). Foxp3DTR mice allow for specific
elimination of Foxp31 Tregs in vivo through
intraperitoneal administration of diphtheria
toxin (DT) (29, 30). This results in selective
depletion of Tregs without significant
systemic toxicity (30). Fgf72/2 mice (B6;129-
Fgf 7tm1Efu/J, designated kgf null hereafter)
were obtained courtesy of Dr. Wendy Havran
and Dr. Elaine Fuchs (20).
Preparation of Mice
Male mice were anesthetized with
tribromoethanol before tracheal intubation
as previously described (15, 16). The
mice were administered LPS or DT, or
underwent left-lung pneumonectomy
(PNX) as previously described (18). Details
regarding the methods used in this study
and other procedures are provided in the
online supplement.
RNA Isolation and Analysis of Relative
Gene Expression
RNA was isolated from snap-frozen cells
stored at 2808C using the Zymo Direct-zol
RNA MiniPrep with TRI-Reagent (Zymo
Research, Irvine, CA) according to the
manufacturer’s protocol with the
modifications described in the online
supplement. TaqMan Universal PCR
Master Mix, no AmpErase UNG from
ThermoFisher Scientific (Waltham, MA)
was used for RT-PCR analysis.
Immunoblot Analysis
Whole-lung samples were homogenized and
cells were lysedwith radioimmunoprecipitation
assay buffer (RIPA buffer; Santa Cruz
Biotechnology Inc., Dallas, TX) as
previously described (15).
Isolation of WT and kgf Null
CD41CD251 Tregs, and Adoptive
Transfer
Spleens from male and female C57BL/6J
or kgf null mice were removed and
prepared for single-cell suspensions,
and Tregs were isolated as detailed in
the online supplement. Adoptive transfer
(AdTr) of Tregs (1 3 106) was performed
1 h after LPS treatment or PNX by
retro-orbital injection into Treg-
depleted Foxp3DTR mice as previously
described (30).
AT2 and Treg Coculture Experiments
Single-cell suspensions were labeled for
surface markers, and sorting was performed
as detailed in the online supplement.
Lymphocyte Culture
Splenic or lung CD41CD251 cells were
isolated by magnetic-bead separation
(Stemcell Technologies, Vancouver,
Canada) and cultured as detailed in the
online supplement.
Isolation of Lymphocytes from Human
Lungs and Immunophenotyping
Human lung tissue was procured
through the Cystic Fibrosis Center Tissue
Procurement and Cell Culture Core of
the Marsico Lung Institute under
protocols approved by The University
of North Carolina Office of Research
Ethics Biomedical Institutional Review
Board. Human lymphocytes were
isolated from distal human lung tissue from
donor lungs that were not accepted for
transplantation by enzymatic digestions
to obtain single-cell suspensions for flow-
cytometry analysis. The methods used are
described in detail in the online supplement.
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Statistics and Sample Size
Calculations
Pairwise comparisons were made by using
Student’s t-test or the Mann–Whitney rank
sum test. When more than two conditions
were compared, P values determined by
Kruskal–Wallis ANOVA with post hoc
Dunn’s test were used to identify specific
differences between groups. Data are
expressed as the mean 6 SEM. Statistical
analysis was performed using GraphPad
Prism 5 software (La Jolla, CA). Statistical
difference was accepted at P , 0.05.
Results
kgf Increases during Resolution of
LPS-Induced ALI, and CD41Foxp31
Cells Express kgf
After intratracheal administration of LPS
to wild-type (WT) mice, kgf expression
increased more than 2-fold by 7 days, as
determined by immunoblot analysis of
whole-lung lysates, compared with
uninjured WT controls (Figure 1A). To
determine whether Tregs directly express
kgf, single-cell suspensions from
enzymatically digested lung tissue from
Foxp3EGFP mice were utilized for cell
sorting to obtain purified populations
of Tregs for transcriptional analysis.
CD41GFP2 (CD41 lymphocyte control)
and CD41GFP1 (Foxp31 Tregs) cells were
sorted 7 days after LPS. RNA was isolated
from the two populations for real-time
RT-PCR analysis to determine Foxp3, Areg,
and Kgf transcription levels normalized
to 18s ribosomal RNA. As expected, the
CD41GFP1 sorted cells were greatly
enriched in Foxp3 expression. Importantly,
these Tregs produced manyfold more
Areg and Kgf transcripts compared with
CD41GFP2 lymphocyte controls
(Figure 1B). These observations indicate
that LPS induces kgf expression and
Foxp31 cells express Areg and Kgf.
Epithelial Proliferation after
LPS-Induced ALI Is Impaired in
kgf Null Mice
To examine the role of kgf in lung repair, we
compared injury and epithelial kinetics
during resolution from LPS-induced injury
in kgf null mice and two WT strains,
C57BL/6J (B6) and 129S1/SvlmJ (129S).
These studies were based on previous
reports that kgf can affect alveolar innate
immune functions and AT2 epithelial
proliferation (23–25). The kgf null mice were
constructed on a mixed C57BL/6 and 129S
background (20). Both WT strains were used
to determine potential differences in specific
cell populations compared with kgf null
mice, as different strains may have variation
in epitopes for the antibodies used for
immunophenotyping with flow cytometry.
The LPS-induced lung injury resolved
similarly in all three strains, as measured by
recovery of weight loss after injury
(Figure 2A). There were no differences
among the three strains with regard to the
percentages of CD41 or CD41Foxp31 cells
in the BAL compartment (Figures 2B and
2C), and no differences in CD31, gd1, or
Foxp31 T cell percentages among the three
strains after Percoll enrichment for
lymphocyte populations in whole-lung
single-cell suspensions (Figures 2D–2F).
Overall, these observations indicate that all
three strains resolved from LPS-induced
inflammation similarly, with no difference in
the observed percentages in Foxp31 cells.
To examine potential changes in
specific lung epithelial cell populations, we
built upon published methods of examining
alveolar epithelial populations using
multicolor flow cytometry of lung single-cell
digests during resolution of lung injury
(see Figure E1A in the online supplement
for the gating scheme) (15, 31–35). In
the single-cell lung suspensions, there was
an increase in the total number of cells
obtained from the 129S background
strain compared with the other two
strains (Figure 2G). The percentages of
hematopoietic (CD451), endothelial
(CD311), and CD312CD452 populations
did not differ among the three strains at
7 days after injury (Figure E1B).
The CD312CD452 population
includes epithelial cells, which can be
identified using the pan-epithelial marker
CD3261 (Figure E1A), as well as all
mesenchymal and neural cells (15). Specific
epithelial populations (AT1, AT2, club, and
cilia cells) can be further delineated in
CD3261 cells by using antibodies to the
cell-surface proteins CD104, CD24,
MHCII, and T1a (Figure 2H; further
description in the online supplement and
Figure E1A) (15, 35). The lungs of kgf null




















































































































Figure 1. Keratinocyte growth factor (kgf) expression increases in the lung during acute lung
injury (ALI) resolution. (A) Wild-type (WT; C57BL/6J) mice were challenged with LPS (3 mg/kg)
intratracheally (IT), and whole-lung lysates were measured for kgf and b-actin expression by
immunoblot analysis 7 days after injury (n = 4 per group, blots representative of two separate
experiments). P value determined by Mann–Whitney. (B) CD41GFP2 (CD41 lymphocyte control)
and CD41GFP1 (Foxp31 Tregs) cells were sorted from the lungs of Foxp3EGFP mice (cells pooled
from . 10 mice) 7 days after LPS administration. Real-time PCR quantification of RNA obtained from
both cell populations was used to quantitate forkhead box p3 (Foxp3), Amphiregulin (Areg), and Kgf
transcription levels, which were then normalized to 18s ribosomal RNA (n = 3 replicates; data shown are
representative of three independent experiments). *P, 0.001 by Student’s t-test. Tregs, regulatory T cells.
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Figure 2. Alveolar epithelial proliferation is markedly impaired in kgf null mice during ALI resolution. C57BL/6J (B6), 129S, and kgf null mice (n = 6 – 17 per
group) were challenged with LPS (3 mg/kg) intratracheally and harvested at Day 7 after LPS treatment. (A) Body weight relative to baseline plotted after injury.
(B and C) Percentages of alveolar CD41 and CD41Foxp31 cells 7 days after treatment with LPS. (D and E) Single-cell lung suspensions subjected to
Percoll gradients for lymphocyte enrichment were then used with flow cytometry to determine the percentages of (D) CD31 T, (E) gd1 T, and (F) Foxp31 cells
in each strain. Data are representative of two separate experiments. No significant difference was determined by Kruskal–Wallis ANOVA in the three
populations. (G–L) Single-cell lung suspensions were obtained from harvested lungs at Day 7 after LPS treatment for identification of epithelial populations: (G)
total lung cell count; (H) representative dot plot labeling the subgating of CD3261 cells and identifying cilia, club, type II alveolar epithelial cells (AT2), and type I
alveolar epithelial cells (AT1) cells; and the percentage of lung digest that consisted of (I) CD3261 epithelial cells or (J) AT2 cells. The percentage of cells
that were proliferating was identified by Ki-67 expression for (K) epithelial cells (CD3261Ki-671) and (L) AT2 cells using flow cytometry. Gating and dot-plot
results are representative of at least three independent experiments. P values were determined by Kruskal–Wallis ANOVA followed by post hoc Dunn’s test to
determine specific differences between groups. *P < 0.05, **P < 0.01, ***P < 0.001. BAL, bronchoalveolar lavage; MHC, major histocompatibility complex.
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epithelial cells, as measured by CD326
expression, compared with the 129S strain,
but not the C57BL/6 strain (Figure 2I).
Importantly, the percentage of AT2 cells
was significantly lower in the kgf null
strain compared with the two WT strains
(Figure 2J). The percentage of AT1 cells
was similar among the three strains (Figure
E1B). The 129S mice had lower percentages
of club and cilia cells compared with the
other two strains by this antibody-based
identification method (Figure E1B).
To determine the contribution of kgf
to epithelial proliferation after injury, the
percentages of epithelial cell populations
staining for Ki-67, a marker of proliferation,
were quantified (Figures E1A and E1B) (36).
We previously detected an increase in
epithelial cell (CD3261) proliferation
(Ki-671), which peaked 7 days after LPS
injury, compared with proliferation in
uninjured lungs (15). At 7 days after
LPS injury, the kgf null mice had lower
percentages of proliferating CD3261 cells and
AT2 cells compared with the two WT strains
(Figures 2K and 2L). These results indicate
that kgf plays a critical role in modulating
alveolar epithelial proliferation after injury.
Transfer of kgf Null Tregs into Treg-
Depleted Mice Fails to Augment
Epithelial Proliferation after LPS-
Induced ALI
To determine the role of kgf expressed by
Tregs in mediating epithelial proliferation,
we isolated CD41CD251 cells from
uninjured spleens of WT or kgf null mice
and performed intravenous AdTr into
Treg-depleted mice 1 h after exposure to
LPS (Figure 3A) (15, 30). Previous
studies showed that AdTr of WT Tregs
(CD41CD251 lymphocytes) into Rag-12/2
mice restored the percentage of
proliferating CD3261 Ki-671 cells back to
WT levels, whereas AdTr of CD41CD252
lymphocytes did not (15).
To assess whether kgf expression by
Tregs is important for alveolar epithelial
proliferation, we studied two AdTr groups.
Foxp3DTR mice depleted of endogenous
Tregs received either WT Tregs (AdTr WT
Treg) or kgf null Tregs (AdTr kgf null Treg)
1 h after LPS treatment. Foxp3EGFP mice
given intraperitoneal DT and LPS served
as controls.
Histopathology of lung tissue at 7 days
after LPS-induced injury demonstrated
elevated immune cells in a peribronchial
distribution in both the WT and kgf null
Treg AdTr groups compared with the
Foxp3EGFP control group that was not
depleted of Tregs (Figure 3B). In the BAL
compartment, there was an increase in the
percentage of CD31 cells in the AdTr WT
Treg group, and CD41 cells also had an
increase in percentage in both the AdTr
WT Treg and AdTr kgf null Treg groups
(Figures 3C and 3D). Foxp31 cells were
decreased in both the AdTr groups
compared with the control Foxp3EGFP mice;
however, no significant difference between
the two AdTr groups was detected in the
BAL (Figure 3E).
No difference was seen in the total
number of cells obtained from the
enzymatic single-cell suspensions 7 days
after LPS and AdTr among the three
conditions (Figure 3F). The percentages of
CD31 lymphocytes were elevated in both
AdTr groups compared with the Foxp3EGFP
control mice as measured in Percoll-
enriched lymphocyte populations in
whole-lung, single-cell suspensions
(Figure 3G). No difference was detected in
the percentage of Foxp31 lymphocytes in
either the AdTr WT Treg or AdTr kgf
null Treg groups in these Percoll-enriched
lymphocyte preparations; however, the
fact that the Foxp3EGFP mice had a greater
percentage compared with the AdTr groups
demonstrated the incomplete repletion
of Tregs by AdTr (Figure 3H). The
AdTr Tregs were present 7 days after
administration, as detected by measuring
the percentage difference between
endogenous GFP1 Tregs and total Foxp31
Tregs, which includes both endogenous
GFP1 and exogenous Foxp31 cells
(Figure 3I). There was no difference in the
percentage of gd1 T cells among the three
groups in the Percoll preparations (data not
shown). Treg expression of CD103, which
was previously demonstrated to retain
Tregs on epithelial surfaces during LPS
exposure (15), did not differ among the
groups (data not shown). All three groups
recovered weight after injury and had no
difference in mortality after LPS injury
(data not shown).
Flow cytometry of lung digests showed
no difference in the percentage of CD3261
or AT2 cells between conditions (Figures 3J
and 3K), and no difference in other
epithelial population percentages (AT1,
club, or cilia) was detected at 7 days after
injury (data not shown).
Importantly, AdTr of WT Tregs into
Treg-depleted Foxp3DTR mice restored the
percentage of proliferating CD3261 and
AT2 cells back to control levels (Figures 3L
and 3M), with no difference in overall
CD3261 and AT2 cells (Figures 3J and 3K).
These results reinforce the notion that
Foxp31 Tregs have a role in lung epithelial
tissue repair, and indicate that Treg
expression of kgf, at least in part, promotes
proliferation of AT2 cells in this model.
kgf Is Critical to Enhance Epithelial
Proliferation after Left-Lung PNX
To determine whether Treg expression of
kgf can promote epithelial proliferation
independently of its ability to dampen
alveolar inflammation, we studied lung
growth after single-lung PNX. Previous
studies showed that after left-lung PNX
in mice, contralateral lung growth
occurred without significant inflammation
(15, 37, 38). Increased levels of epithelial
proliferation occurred by 7 days after
PNX, and Foxp31 Tregs were increased
in the right lung (15). To further examine
the contribution of Treg-expressed
kgf to epithelial proliferation in a
noninflammatory model of lung growth,
we administered DT to Foxp3EGFP and
Foxp3DTR mice using the same depletion
scheme employed for LPS (Figure 3A)
and subjected them to left-lung PNX.
The pneumonectomized and DT-treated
Foxp3DTR mice were repleted with either
WT Tregs or kgf null Tregs 1 h after PNX.
There were no differences in markers of
inflammation, including BAL total protein
and BAL total cell count (data not shown).
No histological differences between
conditions were detected (Figure 4A).
These observations indicate lower levels of
barrier disruption and immune cell influx
compared with the LPS model. The Treg-
depleted PNX Foxp3DTR mice had lower
percentages of Foxp31 cells in the BAL
compared with the Foxp3EGFP control
group (Figure 4B). Repletion with either
WT or kgf null Tregs resulted in similar
percentages of BAL Foxp31 cells
(Figure 4B). Repletion was far from
complete.
No difference in the number of total
cells in the right lung was seen, as measured
in single-cell lung suspensions (Figure 4C).
However, there was a significantly smaller
percentage of CD3261 cells in the
Foxp3DTR AdTr groups depleted of
endogenous Tregs compared with the
Foxp3EGFP control (Figure 4D). There was
also a decrease in AT2 cells in the AdTr
ORIGINAL RESEARCH
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Figure 3. Adoptive transfer (AdTr) of WT Tregs, but not kgf null Tregs, augments epithelial proliferation after ALI. (A) Foxp3EGFP (EGFP) or Foxp3DTR (DTR)
mice (n = 6–11 per group) were challenged with LPS (Day 0) intratracheally and 50 mg/kg diphtheria toxin (DT) administered intraperitoneally (i.p.) at
Day22, and then 10 mg/kg administered on Days21, 1, 3, and 5. One hour after LPS challenge, the Foxp3DTR mice received 1 3 106 CD41CD251 cells
from either C57BL/6J (WT) or kgf null mice, and lungs were harvested on Day 7 after LPS administration. (B) Hematoxylin and eosin (H&E) stain of
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WT Treg group compared with the
Foxp3EGFP control (Figure 4E). This
decrease in total CD3261 cells in Foxp3DTR
depleted mice is due to the elimination
of endogenous Tregs (15, 29).
Strikingly, at 7 days after PNX, the mice
lacking Tregs (PNX Foxp3DTR and no
AdTr) or mice repleted with kgf null Tregs
had significantly lower percentages of
CD3261 proliferation (CD3261 Ki-671)
and AT2 proliferation when compared with
either mice without Treg depletion
(Foxp3EGFP control group) or depleted
mice repleted with WT Tregs 7 days
after PNX (Figures 4F and 4G). Even
the partial repletion of WT Tregs fully
restored the proliferative capability of
CD3261 and AT2 cells. These observations
indicate a critical role for Treg expression
of kgf in enhancing epithelial proliferation
in a noninflammatory model of alveolar
epithelial growth that is similar to its role
in repair after an inflammatory injury.
Treg Expression of kgf Enhances
Proliferation of AT2 Cells In Vitro
Our previous work demonstrated a direct
pro-proliferative effect of Tregs on primary
AT2 cells when grown together in vitro (15).
To determine whether Treg-expressed kgf
could modify epithelial proliferation, we
sorted primary AT2 cells from SP-CGFP
mice, and cocultured with either WT or kgf
null Tregs (CD41CD251) at a 1:5 ratio of
lymphocytes to AT2 cells similar to
previously described (15). AT2 cells
cocultured for 24 h with unstimulated WT
Tregs had higher rates of proliferation
compared with those cultured with kgf
null Tregs or AT2 cells grown in media
alone (Figure 5A).
WT or kgf null Tregs were isolated,
grown, and expanded by T cell receptor
(TCR) stimulation (anti-CD3/CD28 and
recombinant IL-2 500 IU/ml) in vitro for
3 days and then cocultured with freshly
sorted AT2 cells for 24 h. AT2 cells
cocultured with TCR-stimulated WT Tregs
proliferated more than AT2 cells cultured
with TCR-stimulated kgf null Tregs
(Figure 5B). AT2 cells cocultured with
either TCR-unstimulated WT or kgf
null Tregs after 3 days of in vitro growth
had similar, albeit smaller, increases in
rates of AT2 proliferation (Figure 5B).
These data demonstrate that Treg-derived
kgf expression directly promotes primary
AT2 cell proliferation in vitro.
Treg Expression of kgf Varies
Depending on the Tissue Source of
Treg Isolation
Previous studies have demonstrated that
specific cytokines, IL-18 and IL-33, increase
Treg expression of the growth factor Areg
(17, 18). To assess the potential influence
of these cytokines on Treg-derived kgf
expression, Tregs were isolated and
pooled from the spleens or lungs of mice
and then incubated in vitro with the
cytokine IL-1a, IL-18, or IL-33 along
with TCR stimulation using anti-CD3 and
anti-CD28 antibody-coated beads in the
presence of IL-2. Quantification of both
Areg and kgf was performed using
flow cytometry. A larger percentage of
TCR-stimulated Tregs isolated from the
lung tissue expressed Areg and kgf
compared with Tregs isolated from
splenic tissue (Figure 6A) after 3 days of
in vitro culture.
Culture of Tregs with the cytokine
IL-1a, IL-18, or IL-33 along with TCR
stimulation did not lead to an increase in
Areg or kgf expression when compared
with TCR stimulation alone (Figures 6B
and 6C). In addition, these cytokines did
not lead to an increase in Areg or kgf
expression in the absence of TCR
stimulation after 3 days of in vitro culture
(data not shown). Interestingly, Tregs from
lung tissue had a marked increase in
expression of both growth factors when
compared with Tregs isolated from the
splenic tissue from the same mice, as
quantified by the median fluorescent
intensity using flow cytometry (Figures 6B
and 6C). The alarmin IL-33 did not
augment expression of either growth factor
by either lung or splenic Tregs (Figures 6B
and 6C). These results suggest that there is
a differential expression pattern for Treg-
expressed Areg and kgf depending on the
tissue of isolation.
Tregs Isolated from Human Distal
Lung Samples Express Areg and kgf
with Ex Vivo Stimulation
Previous studies demonstrated that Tregs are
present in the BAL of humans with ALI (19).
To determine whether our findings extend
to human Tregs, we sought evidence of
AREG or KGF growth factor expression in
Tregs present in distal human lung tissue.
Human lung tissue was obtained from
donor lungs that were deemed not
acceptable for transplant, and Tregs were
isolated by enzymatic digestion and
lymphocyte enrichment. Subsets of these
lymphocyte enrichments underwent cell
activation for 3 h with phorbol 12-myristate
13-acetate, ionomycin, and brefeldin A
before evaluation of AREG or KGF
expression by intracellular flow cytometry.
Under stimulated conditions, the
percentage of CD41FOXP31 cells
expressing either AREG or KGF increased
compared with unstimulated controls
(Figure 7). These findings indicate that
human Tregs have the ability to express
these growth factors under stimulated
conditions ex vivo.
Discussion
Earlier studies demonstrated that Foxp31
Treg cells enhanced alveolar epithelial
proliferation in two mouse models of lung
regeneration (15). The models were LPS-
induced injury, which has been well
characterized for eliciting alveolar epithelial
damage (15, 39, 40), and left-lung PNX, in
which epithelial proliferation and alveolar
Figure 3. (Continued). representative lung sections on Day 7 after LPS, intraperitoneal DT, and AdTr of the designated lymphocyte subsets. Gray
scale bar, 1 mM; black scale bar, 500 mM; maroon scale bar, 250 mM; green scale bar, 100 mM. (C–E) Identification of BAL immune cells in Foxp3EGFP,
Foxp3DTR AdTr WT Treg, and Foxp3DTR AdTr kgf null Treg mice after treatment with LPS and intraperitoneal DT 7 days after LPS. (C) BAL percentage of
CD31 T cells, (D) CD41 T cells, and (E) CD41Foxp31 cells. (F) Total lung cell count from single-cell suspensions. (G–I) Lung single-cell suspensions were
subjected to Percoll lymphocyte enrichment and then used with flow cytometry to determine the percentages of (G) CD31, (H) Foxp31, and (I)
endogenous Treg (GFP1) versus AdTr Treg and endogenous (Foxp31) cells. (J–M) Single-cell lung suspensions were obtained from harvested lungs
at Day 7 after LPS for identification of epithelial populations. (J) Total CD3261 and (K) AT2 cell percentages along with the percentages of (L) proliferating
CD3261 cells (CD3261Ki-671) and (M) AT2 cells as determined by flow cytometry. P values were calculated by Kruskal–Wallis ANOVA followed by
post hoc Dunn’s test to determine specific differences between groups. *P < 0.05, **P < 0.01, ***P < 0.001. n.s., not significant.
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AdTr Kgf null Tregs
Foxp3EGFP Foxp3DTR
Figure 4. kgf is critical to enhance epithelial proliferation after left-lung pneumonectomy (PNX). Adoptive transfer (AdTr) of C57BL/6J (WT) Tregs augments
epithelial proliferation after left-lung PNX compared with AdTr of kgf null Tregs. Foxp3EGFP (EGFP) or Foxp3DTR (DTR) mice underwent left-lung PNX (Day 0)
after intraperitoneal administration of DT (50 mg/kg on Day 22 and then 10 mg/kg on Days 21, 1, 3, and 5). One hour after PNX, the Foxp3DTR mice
received either 13 106 CD41CD251 WT or kgf null cells (or no cells), and the right lung was harvested on Day 7 after PNX. (A) H&E stain of representative
lung sections after PNX, intraperitoneal DT, and AdTr of the designated lymphocyte subsets to reveal morphologic changes 7 days after the procedure.
Blue scale bar, 200 mM; green scale bar, 100 mM. (B) BAL CD41Foxp31 cells were identified by flow cytometry for all four conditions after PNX, DT
administration, and AdTr of either WT or kgf null Tregs at 7 days after PNX. (C–G) Single-cell lung suspensions were obtained from harvested lungs on
Day 7 after LPS treatment for identification of epithelial populations. (C) Total right-lung cell count, (D) percentages of CD3261 and (E) AT2 single cells, and
percentages of (F) proliferating CD3261 cells (CD3261Ki-671) and (G) AT2 cells were determined by flow cytometry 7 days after PNX (n = 4–9 per
group). P values were calculated using Kruskal–Wallis ANOVA followed by post hoc Dunn’s test to determine specific differences between groups.
*P < 0.05, **P < 0.01.
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regeneration occur in the absence of almost
any inflammation (15). Furthermore, our
previous work demonstrated a direct
effect of Tregs in enhancing AT2 cell
proliferation in vitro in a contact-
independent manner (15). These findings
led us to examine soluble factors. Several
growth factors are important for lung
epithelial repair, with kgf being one of the
better-characterized factors (17, 25). Now,
in this report we pursue the mechanisms
by which Foxp31 Tregs act, importantly
demonstrating that Foxp31 Tregs express
kgf and that Treg-derived kgf enhanced
the rate of epithelial proliferation in both
models. Additionally, in vitro cocultures of
AT2 cell with Tregs lacking expression of
kgf failed to augment AT2 proliferation.
These findings broaden our understanding
of Treg-promoted epithelial repair and
reveal the underlying mechanism.
The mechanisms underlying epithelial
regeneration after injury involve cellular
interactions with extracellular matrix,
paracrine and autocrine signaling factors,
immune cells, and progenitor cell
populations (41–43). The paradigm for
alveolar epithelial repair has been that
AT1 cells are damaged and AT2 cells
undergo hyperplasia, cell spreading, and
proliferation at sites of injury to reestablish
an intact functional epithelial barrier
for gas exchange (10, 44, 45). Recent
reports highlight that not only the etiology
of the injury but also the severity of
the injury may influence the reparative
dynamics in the lungs, along with
influencing the contribution of certain
progenitor populations in epithelial












































































Figure 5. C57BL/6J (WT) Tregs, but not kgf null Tregs, augment epithelial proliferation of AT2 cells
in vitro. Primary AT2 cells were isolated by sorting GFP1 cells from SP-CGFP mice and cocultured with
either WT or kgf null CD41CD251 lymphocytes at a lymphocyte/AT2 ratio of 1:5. The fold increase
(compared with media alone) in proliferation (CD3261Ki-671) was determined after 24 h of coculture
of freshly sorted AT2 cells with either purified WT or kgf null CD41CD251 lymphocytes isolated
from splenocytes. (A) Cocultures of unstimulated lymphocytes and AT2 cells immediately after
isolation of both cell types (n > 8, from three independent experiments combined for each condition).
P values determined by Mann–Whitney. (B) TCR stimulated (anti-CD3/CD28 beads and IL-2 [500
IU/ml]) or unstimulated WT or kgf null CD41CD251 splenic lymphocytes were grown in vitro for 72 h
and then cocultured for 24 h with AT2 cells sorted the day of coculture. Data are representative of
one of two independent experiments, n > 4 for each condition. P values were determined by
Kruskal–Wallis ANOVA with post hoc Dunn’s test used to determine specific differences between
















































































































































Figure 6. The Treg expression levels of the growth factors AREG and KGF after 3 days of in vitro expansion are dependent on the tissue from which
the lymphocytes were isolated. CD41CD251 lymphocytes were isolated from either lung or splenic tissue and grown in TCR-stimulating conditions
(anti-CD3/CD28 beads) and IL-2 (500 IU/ml) in the presence or absence of IL-1a, IL-18, or IL-33 (cytokine concentration: 100 ng/ml). (A) Representative
histogram of intracellular staining for AREG or KGF expression in Foxp31 cells. CD41CD251 lymphocytes were first isolated from either lung or splenic
tissue and then expanded in vitro by TCR stimulation for 3 days. (B and C) Median fluorescent intensity (MFI) of AREG (B) or KGF (C) in Foxp31 cells after
3 days of in vitro growth with TCR stimulation, IL-2 (500 IU/ml), and in some conditions the cytokine IL-1a, IL-18, or IL-33 at a concentration of 100 ng/ml.
The data combine the results of four independent experiments. P values were determined by Kruskal–Wallis ANOVA with post hoc Dunn’s test used
to determine specific differences between groups. *P < 0.05, **P < 0.01.
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Fgfs are a family of signaling molecules
that are involved in embryonic
development, wound healing, cellular
proliferation, and differentiation (47). There
are 22 known Fgfs and 4 Fgf receptors (47).
kgf (Fgf-7) signals through the Fgfr2b
receptor (47). Administration of
recombinant kgf in numerous mouse
models of lung injury has been found to
be protective (for review see Ref. 25).
Interestingly, human subjects administered
recombinant human KGF and then
exposed to inhaled LPS were shown to have
increased phagocytic uptake of bacteria by
alveolar macrophages and increased BAL
concentrations of surfactant protein D,
MMP-9, GM-CSF, and IL-1Ra (23). The
numerous protective effects demonstrated
in animal and human models led to a
clinical trial for recombinant KGF in
ARDS, the results of which are pending
publication (26).
Remarkably, while this work was in
progress, Arpaia and colleagues (17)
demonstrated that Tregs express another
growth factor, Areg, which was found to
be important for viral clearance in an
influenza model of lung injury. Tregs are
not the first lymphocyte population that
has been demonstrated to express kgf:
previous studies found that intraepithelial
gd T cells can induce epithelial proliferation
by expression of kgf (21). To our
knowledge, this is the first report to
demonstrate kgf expression by Foxp31
lymphocytes, and to show a role for Treg-
specific expression of kgf in promoting
repair after ALI.
The AdTr experiments we performed
here in both LPS and PNX models
demonstrate that a deficiency of Treg-
derived kgf expression affects AT2
proliferation. For these studies, we elected to
use Tregs obtained from spleens, which
are predominantly natural Tregs (nTregs;
also known as thymically derived Tregs),
because our previous work demonstrated
a clear role for them in resolution.
Using nTregs also allows the lung
microenvironment to generate the tissue-
specific effects that influence Treg function
during injury. Using nTregs from the spleen
provides a purer population of Tregs than
would be obtained from the lungs
or generated by in vitro induction. The
percent purity of Foxp31 cells in the splenic
CD41CD251 population is 85–90%,
compared with 55–65% in the lung (16).
Importantly, recent published studies by
several groups have demonstrated a tissue-
specific influence on the transcriptional
prolife of Foxp31 Tregs (17, 18). However,
the contribution of nTregs and induced
Tregs may vary in both the immune-
suppression and tissue-repair functions of
Foxp31 cells.
In the initial study of Foxp3DTR mice
in which Tregs were selectively depleted,
the lack of Tregs led to expanded immune-
cell subsets, including CD41 and CD81
lymphocytes (29). Notably, in our studies,
histology sections of both AdTr groups
showed an increase in immune cells around
airways and blood vessels compared with
the Foxp3EGFP controls. This increase in
immune cells was further quantitated by
flow-cytometric measurements, which
documented an increased percentage of
CD31 T cells in lung single-cell suspensions
for the AdTr groups compared with
Foxp3EGFP controls. The AdTr of
exogenous Tregs did not fully replete the
depletion of endogenous Treg in Foxp3DTR
mice (Figure 3I) and thus did not prevent
the expansion of immune subsets in our
experiments. These AdTr results suggest that
far fewer Foxp31 Tregs are required for the
production of sufficient kgf to restore
epithelial cell proliferation than are needed to
induce immunosuppressive effects.
Fgfr2b signaling has been demonstrated
to be important for lung repair in an
influenza model of lung injury (34). Both kgf
and Fgf10 signal through the Fgfr2b
receptor (47). Quantius and colleagues (34)
also evaluated AT2 proliferation in kgf null
mice 7 days after influenza infection (an
early time point in such injury) and
detected no difference between kgf null and
WT mice. These data support the emerging
concept that different stimuli induce
different host responses, and thus different
mechanisms may underlie the reparative
processes. Interestingly, Fgf10 has been
demonstrated to play a larger role in
signaling for cell migration, whereas kgf
promotes a more cell-proliferative response
through Fgfr2B (47).
A contribution of Treg-expressed kgf
to epithelial repair through modulation of
another cell type cannot be completely
excluded, but the in vitro coculture
experiments support a direct interaction
and effect of Treg-expressed kgf on AT2
proliferation. A yet-to-be examined
possibility that would be in line with our
prior contact-independent findings is that
Treg-derived microparticles or exosomes
that are able to pass through transwell
pores may be enriched for growth factors
such as kgf or contain RNA, which could
enhance proliferation and repair (15). Tregs
have been reported to produce more
exosomes than other lymphocyte subsets,
and packaging of KGF RNA by human
mesenchymal stem cell–derived
microvesicles has been demonstrated to
reduce inflammation in LPS-treated
mice (48, 49).
Arpaia and colleagues (17) recently
concluded that lung Tregs play a distinct
role in tissue repair separate from
suppression of inflammation, and further
demonstrated that expression of Areg by
Tregs is enhanced by the cytokines IL-18
and IL-33, but not TCR stimulation. Our
findings differ in that TCR stimulation
did enhance Areg and kgf expression in
Foxp31 cells, and the addition of IL-18 or
IL-33 did not further augment expression
(Figures 5B, 6B, and 6C). There are several
possible explanations for these findings.
First, the majority of our in vitro
experiments were performed using Tregs
isolated from spleens, due to the increased
number of Foxp31 cells from this source.
However, when lung resident Tregs were
isolated, the level of expression of Areg and
kgf was higher than that found for splenic
Tregs as measured by flow cytometry



















Figure 7. Tregs (CD41FOXP31) isolated from
human lung tissue and stimulated ex vivo express
AREG and KGF. Human lymphocytes were isolated
from distal human lung tissue from donor lungs
that were deemed not acceptable for transplant by
enzymatic digestions and Percoll enrichment for
lymphocytes. Lymphocytes were unstimulated
or stimulated for 3 h with phorbol 12-myristate
13-acetate and ionomycin in the presence of
brefeldin A. CD41FOXP31 cells expressing AREG
or KGF were identified by flow cytometry. Data
are representative of one of three independent
experiments for KGF and two independent
experiments for AREG. FSC, forward scatter.
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did not increase further after addition of
IL-33 in the presence of TCR stimulation.
There are also differences in methodologies
between the two studies. For example, we
did not add recombinant TGF-b1 or IL-7
to our in vitro cocultures, we used different
IL-2 concentrations, we did not stimulate
lymphocytes with phorbol 12-myristate
13-acetate and ionomycin before
administering brefeldin A, and we did
not use the metalloproteinase inhibitor
marimastat. These differences likely explain
the discrepancies between our results and
those of Arpaia and colleagues (17).
Others have demonstrated in studies of
experimental muscle injury in mice that a
distinct population of Tregs accumulate and
function to suppress inflammation, and
these muscle-localized Tregs express Areg,
which is pro-reparative toward muscle
satellite cells (18). The Tregs in the injured
muscle tissue were found to be clonally
expanded and had a transcriptome distinct
from that of other Treg populations (18).
Our in vitro studies show that kgf and Areg
expression differs in Tregs isolated from
uninjured lungs compared with spleens.
Given these findings, the reparative
response of Tregs appears to be strikingly
organ or tissue specific (17, 18).
One potential limitation of this study is
that we did not backcross the kgf null mice
to the C57BL/6J strain, which is the
background strain for Foxp3DTR mice.
However, the lack of difference between the
two founder strains (C57BL/6J and 129S)
in response to LPS-induced injury and
subsequent resolution suggests that little
strain variation exists between these lines
with respect to lung resolution. This notion
is supported by a previous study in which
kgf null mice were backcrossed several
generations to C57BL/6J, and a similar
decrease in AT2 cell proliferation was
detected without a significant difference in
inflammation, as determined by cytokine
expression or immune cell percentages in
BAL fluid at baseline or after bacterial-
induced lung injury (19).
In summary, lung resolution is an
active process, and understanding the roles
of different cell types and their interactions
in the reparative process is critical for
intelligent development of therapeutic
interventions. Lung Tregs express kgf, and
Treg-specific expression of kgf plays a role in
promoting alveolar epithelial proliferation
both during the resolution phase in an
experimental model of lung injury and
during regenerative alveologenesis after
PNX. In vitro experiments demonstrate that
AT2 cells cocultured with kgf null Tregs
proliferate less than AT2 cells cocultured
with WT Tregs. Moreover, Tregs isolated
from the lung express higher levels of
two growth factors, kgf and Areg,
compared with Tregs isolated from
splenic tissue. Lastly, Tregs isolated from
human lung tissue can be stimulated
ex vivo to induce both AREG and KGF
expression. These findings enhance our
understanding of Treg-directed effects on
the lung epithelial reparative processes
during resolution of ALI, and further
support the emerging role of Tregs in
tissue repair (17, 50). n
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